Loading...
Market
What major strategic decision will Grifols make by June 30, 2025?
2
Resolution / Starting Odds
New Acquisition Target • 25%
Restructuring Plan • 25%
Partnership with Another Company • 25%
No Major Change • 25%
Official announcements from Grifols SA
Story
Brookfield Abandons Grifols Acquisition, Stock Plummets
Nov 27, 2024, 09:01 AM
Brookfield Asset Management is reportedly preparing to abandon its plans to acquire Spanish drug-maker Grifols SA due to disagreements over valuation. Grifols' board recently rejected Brookfield's indicative offer, leading to a significant drop in Grifols' stock price. The shares fell as much as 17% after the news broke, with the company's stock plummeting by 12% on the day. The potential withdrawal of the offer has also impacted the broader market, with the IBEX 35 index losing 11,600 points. The Grifols family has indicated they won't support a new bid by a third-party to take the company private.
View original story
Similar markets
Increase Bitcoin holdings • 25%
Invest in another cryptocurrency • 25%
Invest in traditional assets • 25%
No major investment move • 25%
Acquisition of another company • 25%
Launch of a new drug • 25%
Restructuring or cost-cutting measures • 25%
Other strategic move • 25%
New clinical trial for different vaccine • 25%
Partnership with another biotech company • 25%
Company restructuring or layoffs • 25%
Other • 25%
Biotech Company • 25%
Pharmaceutical Company • 25%
Medical Device Company • 25%
No major acquisition • 25%
Wave Life Sciences • 25%
CRISPR Therapeutics • 25%
Moderna • 25%
Other • 25%
Merger • 25%
Acquisition • 25%
Partnership • 25%
No significant action • 25%
Expansion into new markets • 25%
Introduction of new services • 25%
Layoffs or restructuring • 25%
Other • 25%
Launches new product • 25%
Announces partnership • 25%
Pursues merger/acquisition • 25%
No major move • 25%
New acquisition • 25%
New partnership • 25%
New product launch • 25%
No major moves • 25%
New Partnership • 25%
New Product Launch • 25%
Leadership Change • 25%
No Major Move • 25%
Remain standalone • 25%
Merge with another entity • 25%
Rebrand • 25%
Other • 25%